NANCY DENYES - 24 May 2022 Form 4 Insider Report for aTYR PHARMA INC (LIFE)

Role
General Counsel
Signature
Nancy E. Denyes
Issuer symbol
LIFE
Transactions as of
24 May 2022
Transactions value $
$0
Form type
4
Filing time
26 May 2022, 16:34:50 UTC
Previous filing
07 Feb 2022
Next filing
06 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LIFE Common Stock 3,447 24 May 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LIFE Employee Stock Option (right to buy) Award $0 +88,097 $0 88,097 24 May 2022 Common Stock 88,097 $2.81 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 178 shares each acquired under the Company's 2015 Employee Stock Purchase Plan (ESPP) on November 15, 2021 and May 13, 2022, respectively.
F2 The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning June 24, 2022, such that this option will be fully exercisable on May 24, 2026. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer.